Live Analyst Rating Changes 42687 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Seema Sheoran
RR

Seema Sheoran

Rodman & Renshaw
Wall Street Analyst
★★★☆☆
#1423
on 13Foresight · ranked by our own returns
50%
Success Rate
-11.1%
Average Return
4 of 8 calls profitable · +46.1% vs benchmark
S&P 500 (SPY)
📈 Across the calls we could measure, roughly 50% of Seema Sheoran's ratings turned a profit when each position was held for 2 year — averaging -11.1% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

7 Buy 0 Hold 0 Sell
Seema's Stock Coverage 7 ratings · 2026-10-16
Company Date Position Consensus ⓘ Price Target ⓘ 2-Yr Return vs S&P 500 ⓘ
IRLA
IRulya Therapeutics
 Sep 24, 2026 BUY Buy
+468.1% avg upside
19 analysts
$70.00
107.57% Upside
 +10.8% ·
ELDN
Eledon Pharmaceuticals
 Jul 21, 2026 BUY Strong Buy
+586.6% avg upside
11 analysts
$12.00
429.88% Upside
 -42.8% ·
NGNE
Neurogene
 Jun 03, 2026 BUY Strong Buy
+113.6% avg upside
24 analysts
$70.00
192.10% Upside
 +0.7% ·
AVXL
Anavex Life Sciences
 May 04, 2026 BUY Strong Buy
+1519.3% avg upside
9 analysts
$20.00
1260.44% Upside
 -56.3% ·
CAMP
CAMP4 Therapeutics Corporation
 Apr 14, 2026 BUY Strong Buy
+186.0% avg upside
9 analysts
$7.00
102.96% Upside
 -24.1% ·
SABS
SAB Biotherapeutics
 Apr 02, 2026 BUY Strong Buy
+313.9% avg upside
14 analysts
$13.00
401.99% Upside
 -35.8% ·
SGMT
Sagimet Biosciences, Inc. Class A
 Mar 26, 2026 BUY Strong Buy
+266.8% avg upside
17 analysts
$28.00
242.39% Upside
 +47.6% ·
🔒 2 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Seema Sheoran — Frequently Asked Questions
How accurate are Seema Sheoran's stock ratings?
Based on the calls 13Foresight could measure, about 50% of Seema's ratings were profitable over a one-year hold, with an average return of -11.1% per rating, or +46.1% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.
How is Seema ranked on 13Foresight?
Seema Sheoran is currently ranked #1423 with a 3-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Seema cover?
Seema most recently has ratings on IRLA, ELDN, NGNE, AVXL, CAMP, SABS, SGMT. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.